New carcinostatic agent with possible selective activity on tumor cells.
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002621:Chemistry; D003102:Colloids; D006801:Humans; D066298:In Vitro Techniques; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007962:Leukocytes / Q000187:drug effects; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009588:Nitrogen Mustard Compounds / Q000138:chemical synthesis / Q000627:therapeutic use*; D011437:Propylamines / Q000138:chemical synthesis / Q000627:therapeutic use; D012995:Solubility; D013535:Suspensions; D013892:Thioxanthenes / Q000138:chemical synthesis / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D003102:Colloids; D009588:Nitrogen Mustard Compounds; D011437:Propylamines; D013535:Suspensions; D013892:Thioxanthenes